1 documents found
Information × Registration Number 0118U004359, R & D request Title A randomized, double blind, placebo-controlled Phase 2 study to evaluate the efficacy and safety of piaavanserin, used as an adjunct to the treatment of negative symptoms of schizophrenia. Head Скрипніков Андрій Миколайович, Registration Date 19-04-2018 Organization Ukrainian medical stomatological Academy popup.description1 popup.nrat_date 2024-12-10 Close
search.res_rk
A randomized, double blind, placebo-controlled Phase 2 study to evaluate the efficacy and safety of piaavanserin, used as an adjunct to the treatment of negative symptoms of schizophrenia.
Head: Скрипніков Андрій Миколайович. A randomized, double blind, placebo-controlled Phase 2 study to evaluate the efficacy and safety of piaavanserin, used as an adjunct to the treatment of negative symptoms of schizophrenia.. Ukrainian medical stomatological Academy. № 0118U004359
1 documents found

Updated: 2026-03-22


Роздрукувати цю сторінку